Monitor whether the company can successfully commercialize its ZSmile platform and generate revenue, as current financials show significant losses and limited cash runway. The IPO proceeds provide temporary funding, but long-term viability depends on product adoption and market penetration in the competitive orthodontic device market.
Executive Summary
Dror Ortho-Design is conducting an IPO to raise approximately $13-15 million by offering 3.6 million shares at $4.13 per share, with proceeds intended for working capital and general corporate purposes. The company has not yet generated revenue, has substantial operating losses, and faces significant risks including its development stage status, regulatory challenges, and ongoing operations in Israel amidst geopolitical tensions. The company recently received FDA 510(k) clearance for its ZSmile platform but has not yet commercialized any products.
Key Financial Metrics
Key Facts
- Company is in development stage with no revenue generation
- Net losses of $2.5 million in 2025 and $5.8 million in 2024
- Received FDA 510(k) clearance for ZSmile platform in February 2026
- Operating in Israel during ongoing military conflicts
- Cash position of $228,000 as of December 31, 2025 with substantial doubt about going concern
- IPO offering of 3,636,364 shares at $4.13 per share, raising $13-15 million
- Proceeds to be used for working capital and general corporate purposes
Financial Impact
$13-15 million in net proceeds from IPO
Risk Factors
- Development stage company with no revenue
- Substantial doubt about going concern due to limited cash and ongoing losses
- Geopolitical risks from operations in Israel
- Intense competition from established orthodontic companies
- Regulatory risks and potential delays in product approvals
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001213900-26-037951 |
| Document: ea028397401ex1-1_drorortho.htm | 0001213900-26-037951 |
| Document: ea028397401ex4-18_drorortho.htm | 0001213900-26-037951 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 16, 2026 5w ago | S-1/A | $0.007400 $0.009000 | ▼ −21.62% | ▼ −20.17% | $0.008500 (−14.86%) |
Aug 19, 2026 9w ago | 8-K | $0.009700 $0.007400 | ▲ +23.71% | ▲ +23.71% | $0.008500 (+12.37%) |
May 1, 2026 25w ago | 8-K | $0.005000 $0.007200 | ▼ −44.00% | ▼ −38.35% | $0.008500 (−70.00%) |
Apr 1, 2026 29w ago | S-1/A | $0.006000 $0.006500 | ▼ −8.33% | ▲ +1.39% | $0.008500 (−41.67%) |
Mar 4, 2026 33w ago | 8-K | $0.007500 $0.006000 | ▼ −20.00% | ▼ −16.21% | $0.008500 (+13.33%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers